445 related articles for article (PubMed ID: 10481869)
1. [Acute and chronic renal failure in patients with myeloma].
Biriukova LS; Volodiaeva EB; Fetisova EV; Pivnik AV; Margolin OV
Ter Arkh; 1999; 71(7):58-64. PubMed ID: 10481869
[TBL] [Abstract][Full Text] [Related]
2. Multiple myeloma--presenting as acute kidney injury.
Prakash J; Niwas SS; Parekh A; Vohra R; Wani IA; Sharma N; Usha
J Assoc Physicians India; 2009 Jan; 57():23-6. PubMed ID: 19753754
[TBL] [Abstract][Full Text] [Related]
3. [Treatment and survival of multiple myeloma patients on programmed hemodialysis].
Rekhtina IG; Ryzhko VV; Chavynchak RB; Biriukova LS
Ter Arkh; 2007; 79(8):9-13. PubMed ID: 17926463
[TBL] [Abstract][Full Text] [Related]
4. [Successful haemodialysis treatment of acute renal failure in a patient with multiple myeloma (author's transl)].
Kopsa H; Schmidt P; Zazgornik J; Balcke P; Deutsch E
Med Klin; 1978 May; 73(18):668-70. PubMed ID: 651757
[TBL] [Abstract][Full Text] [Related]
5. Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy.
Johnson WJ; Kyle RA; Pineda AA; O'Brien PC; Holley KE
Arch Intern Med; 1990 Apr; 150(4):863-9. PubMed ID: 2183734
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with recovery of renal function in patients with multiple myeloma who were treated with hemodialysis.
Katagiri D; Hagiwara S; Minami E; Katsuma A; Masumoto S; Hoshino T; Inoue T; Shibata M; Tada M; Nakamura T; Shimbo T; Hinoshita F
Nephron Clin Pract; 2011; 117(1):c28-32. PubMed ID: 20689322
[TBL] [Abstract][Full Text] [Related]
7. Chronic dialysis in patients with multiple myeloma and renal failure: a worthwhile treatment.
Iggo N; Palmer AB; Severn A; Trafford JA; Mufti GJ; Taube D; Parsons V
Q J Med; 1989 Oct; 73(270):903-10. PubMed ID: 2629022
[TBL] [Abstract][Full Text] [Related]
8. Results and further perspectives of plasmocytoma chemotherapy.
Sakalová A; Hrubisko M; Gazová S; Steruská M; Prümmerová J
Neoplasma; 1986; 33(2):251-8. PubMed ID: 3520353
[TBL] [Abstract][Full Text] [Related]
9. [Development and treatment of renal insufficiency in multiple myeloma].
Mølby L; Hansen HH; Jensen EL
Ugeskr Laeger; 1994 Jul; 156(30):4343-7. PubMed ID: 8066935
[TBL] [Abstract][Full Text] [Related]
10. Melphalan-prednisone versus alternating combination VAD/MP or VND/MP as primary therapy for multiple myeloma: final analysis of a randomized clinical study.
Cavo M; Benni M; Ronconi S; Fiacchini M; Gozzetti A; Zamagni E; Cellini C; Tosi P; Baccarani M; Tura S;
Haematologica; 2002 Sep; 87(9):934-42. PubMed ID: 12217805
[TBL] [Abstract][Full Text] [Related]
11. [Combination chemotherapy (modified M-2 protocol) for multiple myeloma].
Iwata Y; Karitani Y; Tanaka I; Kobayashi T; Ohno T; Kageyama S; Katayama N; Kataoka Y; Kamio N; Ohota C
Rinsho Ketsueki; 1984 Sep; 25(9):1380-7. PubMed ID: 6549187
[No Abstract] [Full Text] [Related]
12. Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of a randomized comparison with vincristine, doxorubicin, and dexamethasone.
Mellqvist UH; Lenhoff S; Johnsen HE; Hjorth M; Holmberg E; Juliusson G; Tangen JM; Westin J;
Cancer; 2008 Jan; 112(1):129-35. PubMed ID: 17973267
[TBL] [Abstract][Full Text] [Related]
13. [Survival of myeloma patients treated with dialysis].
Martín Reyes G; Valera A; Frutos MA; Ramos B; Ordóñez V; López de Novales E
Nefrologia; 2003; 23(2):131-6. PubMed ID: 12778877
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of multiple myeloma and its complications].
Avvisati G; Pulsoni A; Petrucci MT; Tribalto M
Recenti Prog Med; 1990 Oct; 81(10):642-50. PubMed ID: 2291008
[TBL] [Abstract][Full Text] [Related]
15. [Preliminary report of fludarabine, mitoxantrone and dexamethasone in treating refractory or relapsed multiple myeloma].
Luo SK; Li J; Hong WD; Zhao Y; Tong XZ
Ai Zheng; 2005 Dec; 24(12):1518-21. PubMed ID: 16351805
[TBL] [Abstract][Full Text] [Related]
16. Toxicity in standard melphalan-prednisone therapy among myeloma patients with renal failure--a retrospective analysis and recommendations for dose adjustment.
Carlson K; Hjorth M; Knudsen LM;
Br J Haematol; 2005 Mar; 128(5):631-5. PubMed ID: 15725084
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure.
Tosi P; Zamagni E; Cellini C; Cangini D; Tacchetti P; Tura S; Baccarani M; Cavo M
Eur J Haematol; 2004 Aug; 73(2):98-103. PubMed ID: 15245508
[TBL] [Abstract][Full Text] [Related]
18. Managing the complications of plasma cell myeloma.
Cohen HJ; Rundles RW
Arch Intern Med; 1975 Jan; 135(1):177-84. PubMed ID: 122891
[TBL] [Abstract][Full Text] [Related]
19. [Withdrawal of maintenance dialysis in a patient with diagnosed multiple myeloma and renal failure as a consequence of effective anti-tumor treatment].
Rosa J; Sydor A; Jurczyszyn A; Zabawa-Hołyś S; Nowak J; Czapkowicz-Gryszkiewicz L; Sułowicz W
Przegl Lek; 2010; 67(7):547-50. PubMed ID: 21387773
[TBL] [Abstract][Full Text] [Related]
20. Treatment of acute renal failure due to myeloma kidney.
Bear RA; Cole EH; Lang A; Johnson M
Can Med Assoc J; 1980 Oct; 123(8):750-3. PubMed ID: 7004618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]